Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD), Fractyl Health, Inc. (GUTS) and Dogwood Therapeutics (DWTX)
at www.tipranks.com (Wed, 2-Sep 6:20 AM)
Opus Genetics: Buy Rating Reiterated on Upcoming Clinical Catalysts and Solid Cash Runway; $10 Price Target Maintained
at www.tipranks.com (Fri, 28-Aug 2:25 PM)
